Back to video list Back to Home Is there a value of initiating a long-acting injectable if adherence might not be a concern? You may also like Schizophrenia Article From genes to schizophrenia and more Bipolar Schizophrenia Article Family history: great risk requires great help with resilience Depression Congress highlights Article Predicting antidepressant response – problems and promises Migraine Satellite symposium Article New real-world data on the use of calcitonin gene-related peptide monoclonal antibodies for migraine prevention